2018-2023 Global Geriatric Medicine Consumption Market Report

August 2018 | 132 pages | ID: 29769FF68ACEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Geriatric Medicine market for 2018-2023.

Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults
One of the key factors attributing to its rapid growth include rapidly increasing geriatric population base. Furthermore, the rising prevalence of various target diseases, decreasing immunity levels, and the significant improvements in the healthcare systems across the globe is also significantly driving the market growth.
Over the next five years, LPI(LP Information) projects that Geriatric Medicine will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Geriatric Medicine market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Analgesics
• Antihypertensives
• Statins
• Antidiabetics
• Proton Pump Inhibitor
• Anticoagulant
• Antipsychotic
• Antidepressant

Segmentation by application:

• Cardiovascular
• Arthritis
• Neurological
• Cancer
• Osteoporosis
• Respiratory

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• GSK
• Boehringer Ingelheim
• Novartis
• Bristol-Myers Squibb
• Pfizer
• Eli Lilly
• Abbott
• AstraZeneca
• Merck
• Sanofi S.A.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Geriatric Medicine consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Geriatric Medicine market by identifying its various subsegments.
• Focuses on the key global Geriatric Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Geriatric Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Geriatric Medicine submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Geriatric Medicine Consumption 2013-2023
  2.1.2 Geriatric Medicine Consumption CAGR by Region
2.2 Geriatric Medicine Segment by Type
  2.2.1 Analgesics
  2.2.2 Antihypertensives
  2.2.3 Statins
  2.2.4 Antidiabetics
  2.2.5 Proton Pump Inhibitor
  2.2.6 Anticoagulant
  2.2.7 Antipsychotic
  2.2.8 Antidepressant
2.3 Geriatric Medicine Consumption by Type
  2.3.1 Global Geriatric Medicine Consumption Market Share by Type (2013-2018)
  2.3.2 Global Geriatric Medicine Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Geriatric Medicine Sale Price by Type (2013-2018)
2.4 Geriatric Medicine Segment by Application
  2.4.1 Cardiovascular
  2.4.2 Arthritis
  2.4.3 Neurological
  2.4.4 Cancer
  2.4.5 Osteoporosis
  2.4.6 Respiratory
2.5 Geriatric Medicine Consumption by Application
  2.5.1 Global Geriatric Medicine Consumption Market Share by Application (2013-2018)
  2.5.2 Global Geriatric Medicine Value and Market Share by Application (2013-2018)
  2.5.3 Global Geriatric Medicine Sale Price by Application (2013-2018)

3 GLOBAL GERIATRIC MEDICINE BY PLAYERS

3.1 Global Geriatric Medicine Sales Market Share by Players
  3.1.1 Global Geriatric Medicine Sales by Players (2016-2018)
  3.1.2 Global Geriatric Medicine Sales Market Share by Players (2016-2018)
3.2 Global Geriatric Medicine Revenue Market Share by Players
  3.2.1 Global Geriatric Medicine Revenue by Players (2016-2018)
  3.2.2 Global Geriatric Medicine Revenue Market Share by Players (2016-2018)
3.3 Global Geriatric Medicine Sale Price by Players
3.4 Global Geriatric Medicine Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Geriatric Medicine Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Geriatric Medicine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 GERIATRIC MEDICINE BY REGIONS

4.1 Geriatric Medicine by Regions
  4.1.1 Global Geriatric Medicine Consumption by Regions
  4.1.2 Global Geriatric Medicine Value by Regions
4.2 Americas Geriatric Medicine Consumption Growth
4.3 APAC Geriatric Medicine Consumption Growth
4.4 Europe Geriatric Medicine Consumption Growth
4.5 Middle East & Africa Geriatric Medicine Consumption Growth

5 AMERICAS

5.1 Americas Geriatric Medicine Consumption by Countries
  5.1.1 Americas Geriatric Medicine Consumption by Countries (2013-2018)
  5.1.2 Americas Geriatric Medicine Value by Countries (2013-2018)
5.2 Americas Geriatric Medicine Consumption by Type
5.3 Americas Geriatric Medicine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Geriatric Medicine Consumption by Countries
  6.1.1 APAC Geriatric Medicine Consumption by Countries (2013-2018)
  6.1.2 APAC Geriatric Medicine Value by Countries (2013-2018)
6.2 APAC Geriatric Medicine Consumption by Type
6.3 APAC Geriatric Medicine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Geriatric Medicine by Countries
  7.1.1 Europe Geriatric Medicine Consumption by Countries (2013-2018)
  7.1.2 Europe Geriatric Medicine Value by Countries (2013-2018)
7.2 Europe Geriatric Medicine Consumption by Type
7.3 Europe Geriatric Medicine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Geriatric Medicine by Countries
  8.1.1 Middle East & Africa Geriatric Medicine Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Geriatric Medicine Value by Countries (2013-2018)
8.2 Middle East & Africa Geriatric Medicine Consumption by Type
8.3 Middle East & Africa Geriatric Medicine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Geriatric Medicine Distributors
10.3 Geriatric Medicine Customer

11 GLOBAL GERIATRIC MEDICINE MARKET FORECAST

11.1 Global Geriatric Medicine Consumption Forecast (2018-2023)
11.2 Global Geriatric Medicine Forecast by Regions
  11.2.1 Global Geriatric Medicine Forecast by Regions (2018-2023)
  11.2.2 Global Geriatric Medicine Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Geriatric Medicine Forecast by Type
11.8 Global Geriatric Medicine Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 GSK
  12.1.1 Company Details
  12.1.2 Geriatric Medicine Product Offered
  12.1.3 GSK Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 GSK News
12.2 Boehringer Ingelheim
  12.2.1 Company Details
  12.2.2 Geriatric Medicine Product Offered
  12.2.3 Boehringer Ingelheim Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Boehringer Ingelheim News
12.3 Novartis
  12.3.1 Company Details
  12.3.2 Geriatric Medicine Product Offered
  12.3.3 Novartis Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Novartis News
12.4 Bristol-Myers Squibb
  12.4.1 Company Details
  12.4.2 Geriatric Medicine Product Offered
  12.4.3 Bristol-Myers Squibb Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Bristol-Myers Squibb News
12.5 Pfizer
  12.5.1 Company Details
  12.5.2 Geriatric Medicine Product Offered
  12.5.3 Pfizer Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Pfizer News
12.6 Eli Lilly
  12.6.1 Company Details
  12.6.2 Geriatric Medicine Product Offered
  12.6.3 Eli Lilly Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Eli Lilly News
12.7 Abbott
  12.7.1 Company Details
  12.7.2 Geriatric Medicine Product Offered
  12.7.3 Abbott Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Abbott News
12.8 AstraZeneca
  12.8.1 Company Details
  12.8.2 Geriatric Medicine Product Offered
  12.8.3 AstraZeneca Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 AstraZeneca News
12.9 Merck
  12.9.1 Company Details
  12.9.2 Geriatric Medicine Product Offered
  12.9.3 Merck Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Merck News
12.10 Sanofi S.A.
  12.10.1 Company Details
  12.10.2 Geriatric Medicine Product Offered
  12.10.3 Sanofi S.A. Geriatric Medicine Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Sanofi S.A. News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Geriatric Medicine
Table Product Specifications of Geriatric Medicine
Figure Geriatric Medicine Report Years Considered
Figure Market Research Methodology
Figure Global Geriatr